 Connection
Janetta Iwanicki to Analgesics, Opioid
This is a "connection" page, showing publications Janetta Iwanicki has written about Analgesics, Opioid.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.025 |
|
|
|
-
Iwanicki JL, Severtson SG, McDaniel H, Rosenblum A, Fong C, Cicero TJ, Ellis MS, Kurtz SP, Buttram ME, Dart RC. Abuse and Diversion of Immediate Release Opioid Analgesics as Compared to Extended Release Formulations in the United States. PLoS One. 2016; 11(12):e0167499.
Score: 0.269
-
Severtson SG, Haanschoten EE, Iwanicki J, Dart RC. Differences in severity of poison centers exposures involving XTAMPZA® ER versus other opioid analgesics. Pain Manag. 2023 Sep; 13(9):519-527.
Score: 0.108
-
Mutter R, Black J, Iwanicki J. Changes in the Street Prices of Prescription Opioids During the COVID-19 Pandemic. Psychiatr Serv. 2023 01 01; 74(1):63-65.
Score: 0.099
-
Black JC, Rockhill KM, Dart RC, Iwanicki J. Clustering patterns in polysubstance mortality in the United States in 2017: a multiple correspondence analysis of death certificate data. Ann Epidemiol. 2023 01; 77:119-126.
Score: 0.097
-
Black J, Margolin ZR, Bau G, Olson R, Iwanicki JL, Dart RC. Web-Based Discussion and Illicit Street Sales of Tapentadol and Oxycodone in Australia: Epidemiological Surveillance Study. JMIR Public Health Surveill. 2021 12 20; 7(12):e29187.
Score: 0.095
-
Iwanicki JL, Schwarz J, May KP, Black JC, Dart RC. Tramadol non-medical use in Four European countries: A comparative analysis. Drug Alcohol Depend. 2020 12 01; 217:108367.
Score: 0.088
-
Dart RC, Iwanicki JL, Dasgupta N, Cicero TJ, Schnoll SH. Do abuse deterrent opioid formulations work? J Opioid Manag. 2017 Nov/Dec; 13(6):365-378.
Score: 0.072
-
Rockhill KM, Olson R, Dart RC, Iwanicki JL, Black JC. Differing Behaviors Around Adult Nonmedical Use of Prescription Stimulants and Opioids: Latent Class Analysis. J Med Internet Res. 2023 09 20; 25:e46742.
Score: 0.027
-
Severtson SG, Gurrola MC, Parrino MW, Ellis MS, Cicero TJ, Iwanicki JL, Dart RC. Abuse of tapentadol compared to other atypical opioids among individuals entering treatment for opioid use disorders. J Opioid Manag. 2023 Sep-Oct; 19(5):445-453.
Score: 0.027
-
Jewell J, Black J, Ellis M, Olsen H, Iwanicki J, Dart R. A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population. Clin Drug Investig. 2023 Mar; 43(3):197-203.
Score: 0.026
-
Palamar JJ, Cottler LB, Goldberger BA, Severtson SG, Grundy DJ, Iwanicki JL, Ciccarone D. Trends in characteristics of fentanyl-related poisonings in the United States, 2015-2021. Am J Drug Alcohol Abuse. 2022 07 04; 48(4):471-480.
Score: 0.025
-
Fischer LJ, Severtson SG, Gurrola MC, Iwanicki JL, Green JL, Dart RC. Changes in Hydrocodone Misuse Exposures Reported to U.S. Poison Centers Following Rescheduling in 2014. Subst Use Misuse. 2022; 57(7):1097-1103.
Score: 0.024
-
Hockenhull J, Wood DM, Fonseca F, Guareschi M, Scherbaum N, Iwanicki JL, Dart RC, Dargan PI. The association between the availability of over the counter codeine and the prevalence of non-medical use. Eur J Clin Pharmacol. 2022 Jun; 78(6):1011-1018.
Score: 0.024
-
Dart RC, Iwanicki JL, Black JC, Olsen HA, Severtson SG. Measuring prescription opioid misuse and its consequences. Br J Clin Pharmacol. 2021 04; 87(4):1647-1653.
Score: 0.023
-
Geoffrey Severtson S, Kreider SED, Amioka EC, Margolin ZR, Iwanicki JL, Dart RC. Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza ER. Pain Med. 2020 12 25; 21(12):3660-3668.
Score: 0.022
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|